Focus on percutaneous short-term ventricular assist devices: joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices - Part 2. Clinical monitoring and antithrombotic management
22 February 2022, from
European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Professor S. Price (London, GB)
Professor K. Huber (Vienna, AT)
Professor C. Vandenbriele (Leuven, BE)
Needs assessment and expected educational outcome
To learn the parameters of multimodality clinical monitoring in the cath lab and in the CCU/ICU and the drugs to be used with percutaneous PVADs (inotropes, antithrombotics, etc.), as well as management of adjunctive pharmacotherapy support.
After watching this webinar, participants will have learned:
optimal clinical monitoring of percutaneous VAD; and
how to manage antithrombotic therapy during percutaneous VAD
This programme is supported by ABIOMED in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor.